ϩ -buffering capacity. Peak oxygen consumption was 47% less in LTx (P Ͻ 0.05). LTx had lower Ca 2ϩ release (34%), Ca 2ϩ uptake (31%), and Ca 2ϩ -ATPase activity (25%) than controls (P Ͻ 0.05), despite their higher type II fiber proportion (LTx, 75.0 Ϯ 5.8%; controls, 43.5 Ϯ 2.1%). Muscle [H ϩ ] was elevated in LTx (P Ͻ 0.01), but buffering capacity was similar to controls. Muscle 3-O-methylfluorescein phosphatase activity was 31% higher in LTx (P Ͻ 0.05), but [ 3 H]ouabain binding content did not differ significantly. However, during exercise, the rise in plasma [K ϩ ]-to-work ratio was 2.6-fold greater in LTx (P Ͻ 0.05), indicating impaired K ϩ regulation. Thus grossly subnormal muscle calcium regulation, with impaired potassium regulation, may contribute to poor muscular performance in LTx. calcium release; calcium adenosine 5Ј-triphosphatase; Na ϩ -K ϩ pump; muscle fiber type; respiratory disease LUNG TRANSPLANT RECIPIENTS (LTx) exhibit peripheral rather than ventilatory limitations, resulting in grossly impaired exercise performance. Skeletal muscle abnormalities documented thus far include impaired peripheral muscle O 2 extraction, mitochondrial function, and oxidative metabolism (32, 45, 48) ; reduced muscle ATP (48), low muscle pH during exercise (11); and a high type II fiber proportion (48 The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked ''advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. 95: 1606-1616, 2003. First published June 13, 2003 10.1152/japplphysiol.01175.2002 Therefore, the aim of the present study was to explore muscle potassium and calcium regulatory mechanisms implicated in muscular fatigue in humans, to determine whether abnormalities might exist in LTx, in addition to impaired muscle oxidative function (48). Insights gained might have relevance to the pathological processes underlying chronic lung disease, deconditioning due to severe illness, and chronic immunosuppressive therapy and thus have relevance to a wide spectrum of patients.
paired peripheral muscle O 2 extraction, mitochondrial function, and oxidative metabolism (32, 45, 48) ; reduced muscle ATP (48) , low muscle pH during exercise (11) ; and a high type II fiber proportion (48) . Thus peripheral muscular weakness (35) and early muscle fatigue, rather than cardiovascular and respiratory limitations, generally appear to underlie impaired exercise performance in LTx (see reviews in Refs. 2, 50 and also Refs. 1, 24, 32, 45) . Whereas skeletal muscle fatigue is a multifaceted and incompletely understood phenomenon, disturbances in muscle potassium ( (13, 14, 41, 47) . In LTx, there is evidence of impaired K ϩ regulation during exercise, with an abnormally high plasma [K ϩ ] relative to exercise work produced, and a slower postexercise decline in [K ϩ ] (19) . These impairments might be explained by abnormalities in skeletal muscle Na ϩ -K ϩ -ATPase, which could also exacerbate muscle fatigability (14) . Reductions in muscle Na ϩ -K ϩ -ATPase content have been previously reported with chronic inactivity and in heart failure (8) , suggesting a similar possibility in LTx. Furthermore, muscle ATP-dependent Na ϩ /K ϩ exchange might also be impaired in LTx, due to abnormal oxidative metabolism, reflected by their low muscle ATP content and elevated IMP (48) . Therefore, it is possible that abnormalities in muscle Na ϩ -K ϩ -ATPase contribute to an early muscle fatigue and consequent exercise limitation in LTx.
Disturbed intracellular Ca 2ϩ regulation is strongly linked with muscular fatigue. In isolated animal muscle fibers, sarcoplasmic reticulum (SR) Ca 2ϩ release declines with fatigue, resulting in depressed intracellular [Ca 2ϩ ] and contributing to a decline in force output; SR Ca 2ϩ -ATPase activity is also impaired, depressing SR Ca 2ϩ loading as well as the posttetanic decline in cytosolic [Ca 2ϩ ] (see reviews in Refs. 12, 23, 42, 49) . In human muscle, depressed maximal in vitro rates of SR Ca 2ϩ release, Ca 2ϩ uptake, and Ca 2ϩ -ATPase activity have each also been demonstrated with fatigue (7, 26) . There are no reports of muscle SR characteristics in LTx, but abnormalities seem likely. Impaired muscle oxidative metabolism (48) suggests that ATP-dependent Ca 2ϩ release and Ca 2ϩ reuptake processes might also be impaired in LTx and thereby contribute to early muscle fatigue and exercise cessation in LTx. We have shown that LTx exhibit an unusually high proportion of type II fibers (48) , which are typically more fatigable (42) . This abnormal fiber composition may partially result from the immunosuppressant drug cyclosporin A (CsA), which inhibits calcineurin-activated pathways, leading to a slow-to-fast muscle-fiber phenoconversion (5) . Furthermore, there is also evidence in rats that CsA impairs Ca 2ϩ regulation, disturbing myocardial SR Ca 2ϩ release (4) , and in skeletal muscle, depressing Ca 2ϩ -ATPase activity and inducing Ca 2ϩ -ATPase isoform changes (5, 6) . Whether these processes are adversely affected in LTx muscle is unknown.
Therefore, the aim of the present study was to explore muscle potassium and calcium regulatory mechanisms implicated in muscular fatigue in humans, to determine whether abnormalities might exist in LTx, in addition to impaired muscle oxidative function (48) . Insights gained might have relevance to the pathological processes underlying chronic lung disease, deconditioning due to severe illness, and chronic immunosuppressive therapy and thus have relevance to a wide spectrum of patients.
Three hypotheses were tested in this study: 1) that muscle SR Ca 2ϩ regulation (Ca 2ϩ release, Ca 2ϩ uptake, and Ca 2ϩ -ATPase activity) and 2) muscle Na ϩ -K ϩ -ATPase function (content, maximal activity, and
are impaired in LTx relative to healthy controls; and 3) that these abnormalities will be correlated with their impaired exercise performance.
METHODS

Overview
All subjects underwent initial lung function assessment and then performed an incremental exercise test on a cycle ergometer, where arterialized venous blood samples were taken during and after exercise. On a separate occasion, but within 7 days, subjects underwent a muscle needle biopsy procedure under resting conditions. This paper complements previously published work specifying abnormalities in skeletal muscle mitochondrial ATP production rate, metabolites, metabolic enzyme activities, as well as muscle fiber-type composition for seven of these patients (48) .
Subjects
Eight stable LTx comprising five women and three men (age 37.8 Ϯ 10.7 yr, height 168.3 Ϯ 7.8 cm, body mass 64.8 Ϯ 11.2 kg, means Ϯ SD) and eight age-and gender-matched controls (age 37.3 Ϯ 9.7 yr, height 169.5 Ϯ 11.7 cm, body mass 67.1 Ϯ 12.8 kg, means Ϯ SD) volunteered to participate in the study. The mean duration posttransplantation was 13.5 Ϯ 8.7 mo (means Ϯ SD), ranging from 3 to 24 mo. The transplant recipients had stable lung function, with no evidence of recent infection or rejection, having fully rehabilitated after the lung transplant procedure. The controls were sedentary and did not exercise regularly. The diagnoses, operative procedures, and immunosuppressive medication of seven of the patients have been reported previously (48) . An additional patient included here was a 24-mo post-heart and lung transplant female patient (age 43 yr, height 161 cm, body mass 48 kg) diagnosed with patent ductus arteriosis and Eisenmenger's syndrome and treated with trimethoprim and sulfamethoxazole, enalapril, pravastatin, 7.5 mg/day prednisolone, 37.5 mg/day azathioprine, and 300 mg/day CsA with a blood [CsA] trough level of 322 g/l. Details of immunosuppressive medications are indicated in Table 1 (modified  from Ref. 48) . Several medications taken could affect electrolyte regulation. Electrolyte supplements included magnesium for five patients, slow-release potassium in one patient, whereas three patients received calcium. All patients were treated with the glucocorticoid prednisolone; the glucocorticoid dexamethasone increases muscle Na ϩ -K ϩ -ATPase content (9, 38) . One patient was treated with the diuretic 
Muscle Biopsy Sampling and Analyses
A muscle biopsy was taken from the vastus lateralis muscle by the needle biopsy technique by using a BergstromStille needle. In LTx, this procedure was performed while patients were sedated by using pethidine and midazolam at the time of a routine bronchoscopy. Briefly, local anesthesia was obtained by injection of 2% lignocaine into the skin, subcutaneous tissue, and fascia overlying the vastus lateralis muscle. A small incision was then made, and ϳ200 mg of tissue were sampled. One portion of muscle (ϳ30-45 mg) was immediately weighed, diluted 1:10 (wt/vol) in a cold buffer, homogenized, and then frozen in liquid nitrogen for later measurements of SR Ca 2ϩ -ATPase activity, Ca 2ϩ uptake rate, and Ca 2ϩ release rate in crude muscle homogenates, by using methods fully detailed and discussed (26) . Muscle SR Ca 2ϩ -ATPase activity was determined spectrophotometrically, whereas maximal in vitro SR Ca 2ϩ uptake and Ag ϩ -induced Ca 2ϩ release rates in SR vesicles were determined fluorimetrically by using the ratiometric dye indo-1 (26) . A small portion (ϳ10 mg) of muscle was immediately frozen in liquid nitrogen and kept separate for analysis of muscle pH and buffer capacity by using a pH microelectrode and hydrochloric acid titrations, as recently detailed elsewhere (17) . Approximately 20 mg of muscle frozen in liquid nitrogen were used to quantify the Na ϩ -K ϩ -ATPase content by using the [ 3 H]ouabain binding method, as previously described (14, 31) . A small muscle sample (30-40 mg) was homogenized and used to determine the maximal in vitro Na ϩ -K ϩ -ATPase activity, using the K ϩ -stimulated 3-O-methylfluorescein phosphatase (3-O-MFPase) assay, as previously described in detail (14, 15) . Muscle fiber composition was analyzed histochemically by using the myofibrillar ATPase method and was previously reported along with muscle metabolite and enzyme assays (48) . Muscle Na ϩ and K ϩ contents were determined by flame photometry in five LTx and contrasted against nine nonmatched, healthy controls.
Exercise Testing, Blood Sampling, and Analyses
All subjects completed an incremental exercise test on an electronically braked cycle ergometer, but with LTx and control tests conducted at different laboratories for ethical reasons and thus using different equipment, with oxygen uptake, ventilation, and lactate threshold as previously described (48) . LTx performed a 16.3 W/min increment (Siemans-Elema cycle ergometer), with respiratory analyses by using a metabolic measurement cart (Sensormedics, Yorba Linda, CA). Controls performed a 25 W/min increment (Lode cycle ergometer, Groningen, The Netherlands) with respiratory measurements by using our laboratory's previously described system (26) . Arterialized hand dorsal venous blood samples were taken at rest, each minute during exercise, and at 1, 2, 5, and 10 min of recovery, with the hand heated in a 45°C water bath. For controls, blood samples were analyzed in duplicate for plasma acid-base status and gas tensions (H ϩ , PCO2, PO2), for [K ϩ ] by using an automated analyzer (865 Ciba Corning, Bayer), for [Hb] spectrophotometrically (Radiometer OSM2, Copenhagen, Denmark), and for Hct in triplicate after centrifugation (Hettich Zentrifugen D-7200, Tuttlingen, Germany). For LTx, corresponding blood sample analyses were for plasma acid-base status and gas tensions (ABL500 Radiometer), for [K ϩ ] by indirect ion-selective electrodes (Hitachi 747, Boehringer, Mannheim Germany), for [Hb] spectrophotometrically (Radiometer OSM2), and for Hct by using a hematology analyzer (Bayer H2, Leverkusen, Germany). All analytic instruments were calibrated before and during the analyses with precision standards. To ensure compatibility of data collected from the two laboratories, three healthy controls (age 35.3 Ϯ 7.6 yr, height 182 Ϯ 9.1 cm, body mass 90.6 Ϯ 11.4 kg, mean Ϯ SD) performed a maximal incremental exercise test to fatigue in each laboratory, with measurement of respiratory data and arterialized venous blood sampling. Comparisons of peak incremental exercise work rate and respiratory and plasma [K ϩ ] measurements between the two tests yielded only small differences, which include both technical and biological variability.
Slightly lower values were observed in the laboratory used for testing controls compared with LTx for peak work rate (283 Ϯ 8 vs. 325 Ϯ 14 l/min; P Ͻ 0.05) and peak O 2 consumption (V O2 peak) [3.33 Ϯ 0.15 vs. 3.66 Ϯ 0.14 l/min; not signif-
; NS) tended to be higher in the laboratory used for testing controls than for LTx, respectively. These small differences were opposite to those observed between control and LTx (see RESULTS) and, therefore, suggest a small underestimation of the actual differences between control and LTx.
Calculations
The percent decline in plasma volume from rest (⌬PV) was calculated from changes in [Hb] and Hct from rest and the ⌬[K ϩ ] and the ⌬[K ϩ ]/work (as an index of plasma K ϩ regulation), as previously described (14, 31) .
Statistics
All muscle and exercise data were compared by using an independent (unpaired) t-test. Blood data were analyzed by two-way ANOVA (group, sample time) with repeated measures for sample time. Post hoc analyses used the StudentNewman-Keuls test. Correlations between variables were determined by linear regression. Significance was accepted at P Ͻ 0.05. Data are expressed as means Ϯ SE, except where otherwise indicated.
RESULTS
Muscle SR Ca 2ϩ Regulation
The maximal rates of SR Ag release, Ca 2ϩ uptake, and Ca 2ϩ -ATPase activity were, respectively, 28% (P Ͻ 0.05), 26% (P Ͻ 0.05), and 16% (P Ͻ 0.06) less in LTx compared with controls (Figs. 1B, 2B, and 3B, respectively).
SR Ca 2ϩ Regulation Relative to Fiber Composition
LTx exhibited a lower proportion of type I fibers than controls (LTx, 24.9 Ϯ 4.4 vs. controls, 56.1 Ϯ 2.4%; P Ͻ 0.05), as previously reported (48) . The SR data in LTx and controls are plotted relative to muscle fiber proportions, with individual data shown by symbols (Fig. 4) . Also plotted are the SR-fiber-type relationships determined for healthy subjects using these methods in our laboratory. These were determined from previously reported data for 24 healthy controls (26) and included data from the seven controls in this study (i.e., n ϭ 31). These figures clearly demonstrate grossly subnormal results for LTx for each of Ca 2ϩ release, Ca 2ϩ uptake, and Ca 2ϩ -ATPase activity, relative to expected higher values, given their higher proportion of type II fibers (26) .
-ATPase Activity and Content
The maximal in vitro Na Table 2 ) was higher in LTx than in controls when expressed per gram wet weight (31%, P Ͻ 0.05) and also tended to be higher when expressed relative to muscle protein content (18%, P ϭ 0.09). Muscle protein and Na
]ouabain binding site, 12% higher) contents did not differ significantly between LTx and controls ( Table 2) .
Muscle Electrolytes and Buffering Capacity
Neither muscle Na ϩ (LTx, 18.5 Ϯ 3.0 vs. controls, 22.9 Ϯ 2.9 mol/g wet wt) nor K ϩ contents differed significantly between groups (LTx, 72.5 Ϯ 11.7 vs. controls, 78.3 Ϯ 4.1 mol/g wet wt). Muscle [H ϩ ] was higher (i.e., lower pH) in LTx (P Ͻ 0.05), whereas muscle buffer capacity did not differ between the groups (Table 2) .
Pulmonary Function and Incremental Exercise V O 2 peak
Spirometry in LTx showed a mild restrictive ventilatory defect compared with the normal spirometry in controls (vital capacity: LTx, 3.50 Ϯ 0.28 vs. controls, 4.72 Ϯ 0.17 liters; P Ͻ 0.001, n ϭ 8). LTx terminated exercise at substantially lower peak exercise work rates (LTx, 88 Ϯ 8 vs. controls, 222 Ϯ 28 W; P Ͻ 0.001), with a corresponding markedly low V O 2 peak (Ϫ47%; LTx, 18.8 Ϯ 1.5 vs. controls, 35.6 Ϯ 2.4 ml ⅐ kg Ϫ1 ⅐ min
Ϫ1
; P Ͻ 0.001). 
Arterialization, [Hb], Hct, and Fluid Shifts During Exercise
Adequate arterialization was evidenced by high PO 2 in both LTx and controls at rest, peak exercise, and recovery (Table 3) . PO 2 was increased above rest at 5 and 10 min of recovery (P Ͻ 0.05) and was greater in controls than in LTx (91.2 Ϯ 2.4 vs. 76.8 Ϯ 2.4 Torr, respectively; P Ͻ 0.005). In controls (Table 3) , [Hb] was elevated above rest at peak exercise and at 1 and 2 min (P Ͻ 0.05), and Hct was increased at 2, 5, and 10 min of recovery (P Ͻ 0.05). Plasma volume decreased by 11.2 Ϯ 2.1% at peak exercise and remained less than rest at 30 min of recovery (P Ͻ 0.05). In contrast, in LTx, no significant changes from rest were seen in [Hb], Hct, or plasma volume (Table 3 ). Both [Hb] and Hct were lower in LTx than controls at rest, during exercise, and in recovery (P Ͻ 0.05); the decline in plasma volume was greater in controls than in LTx at peak exercise and until 20 min of recovery (P Ͻ 0.05, Table 3 ).
Plasma [K ϩ ] During Incremental Exercise
Plasma [K ϩ ] increased with exercise intensity to peak at fatigue and declined to near rest values by 2 min of recovery in both groups (P Ͻ 0.05, Fig. 5A ). A significant time ϫ group interaction was found for plasma [K ϩ ], which was higher in LTx at rest and throughout recovery (P Ͻ 0.05), but did not differ between groups at peak exercise (Fig. 5A) . Plasma [K ϩ ] was higher in LTx during submaximal exercise when expressed relative to V O 2 peak (Fig. 5B) . }, Controls (n ϭ 7); OE, LTx (n ϭ 7). A linear regression line (thick dashed lines) and 95% confidence interval (thin dashed lines) is shown for SR characteristics in healthy human muscle. Data are combined from our laboratory's previous study comprising 8 untrained, 8 endurance-trained, and 8 resistance-trained individuals (26) and pooled with data from the 7 age-and gender-matched healthy controls in this study (total, n ϭ 31). Regression equations were as follows: Ca 2ϩ release ϭ (0.017 ϫ type II%) ϩ 1.147 (r ϭ 0.56, P Ͻ 0.001); Ca 2ϩ uptake ϭ (0.011 ϫ type II%) ϩ 1.188 (r ϭ 0.56, P Ͻ 0. Values are means Ϯ SE. LTx, 2 single-lung transplants, 2 heart-lung transplants, 4 double-lung transplants. LTx different from controls: * P Ͻ 0.05, † P Ͻ 0.01, ‡ P ϭ 0.09. (r ϭ 0.53). SR Ca 2ϩ uptake was correlated to pooled V O 2 peak , expressed per gram muscle (r ϭ 0.67, P Ͻ 0.01) or per gram protein (r ϭ 0.62, P Ͻ 0.05), as was Ca 2ϩ uptake in controls per gram muscle wet weight (r ϭ 0.74, P Ͻ 0.06). SR Ca 2ϩ -ATPase activity per gram protein was correlated to V O 2 peak for LTx (r ϭ 0.76, P Ͻ 0.05) and tended to correlate for pooled data (r ϭ 0.52, P Ͻ 0.06).
DISCUSSION
We report two major novel findings of abnormal cation regulation in skeletal muscle in LTx, compared with healthy age-and gender-matched controls. Muscle SR Ca 2ϩ regulation was markedly abnormal in LTx, with lower Ca 2ϩ release and Ca 2ϩ uptake rates, as well as Ca 2ϩ -ATPase activity; these differences were even more striking when contrasted to their very high proportion of type II muscle fibers (Fig. 5) . Contrary to expectations, we found that, in LTx, skeletal muscle Na ϩ -K ϩ -ATPase activity was upregulated by 31%, with a tendency also for an increased Na uptake, and Ca 2ϩ -ATPase activity in LTx muscle, relative to controls. These were not simply due to abnormalities in muscle water content, as depressions were found whether they were expressed relative to muscle wet weight or protein content. These abnormalities in LTx muscle are even more profound, given their 31% greater type II fiber proportion (48) , which, in healthy human muscle, exhibits two-to threefold higher rates for each of SR Ca 2ϩ release, Ca 2ϩ uptake, and Ca 2ϩ -ATPase activity (26) .
Critique of SR methods. Our laboratory has recently discussed these methods for investigating human skeletal muscle SR function in detail (26) . Therein, we cite evidence that, whereas Ag ϩ is not the physiological mechanism for induction of Ca 2ϩ release, the Ag ϩ -induced Ca 2ϩ release measurement is specific for the physiological Ca 2ϩ release channel, the ryanodine receptor (RyR). We also provide evidence that our SR Ca 2ϩ uptake measure is mediated by SR Ca 2ϩ -ATPase and that our Ca 2ϩ -ATPase activity measurements are specific to the SR. One limitation of these measurements is that they are conducted by using vesicles in a crude muscle homogenate, under standardized in vitro conditions. Thus our measurements cannot predict in vivo muscle SR Ca 2ϩ fluxes in an intact living fiber, where perturbations in local ATP, phosphate, temperature, pH, glycogen, Mg 2ϩ , and phosphocreatine may each affect function of the RyR and/or the Ca 2ϩ -ATPase enzyme (23, 42) . Nonetheless, it should also be appreciated that no direct method presently exists to study in vivo SR Ca 2ϩ release and/or uptake in human muscle. Our data provide strong evidence of abnormalities in SR in LTx.
Possible Mechanisms of SR Abnormalities in LTx
The predominance of type II muscle fibers in LTx is consistent with a type I-to-II fiber transition with muscular disuse (see review by Ref. 37 ) and with similar findings in patients with chronic obstructive pulmonary disease (20, 44) . However, the immunosuppressant drug CsA, which inhibits calcineurin-activated pathways, also leads to a slow-to-fast muscle-fiber phenoconversion (5) and probably also contributed to their profusion of type II fibers. Regardless of the underlying mechanism(s), correspondingly increased SR functional characteristics would be expected in normally functioning type II muscle fibers. Thus altered fibertype expression without an accompanying increased SR function points to dysfunctional excitation-contraction processes in LTx.
The abnormal SR-fiber-type relationship evident in LTx suggests dissociation between coexpression of myosin ATPase and SR proteins normally observed in fast-twitch muscle, as reported during fast-to-slowfiber transition with chronic electrical stimulation (39) . It is possible that increased SR protein expression that normally occurs in type II fibers is inhibited in LTx muscle.
Hindlimb unweighting in rats increased SR Ca 2ϩ uptake and Ca 2ϩ release rates (43), Ca 2ϩ -ATPase SERCA1 mRNA and protein expression (40) , and RyR protein expression in soleus muscle (21) . Similarly, immobilization or short-term hindlimb suspension in rats increased SR Ca 2ϩ uptake and Ca 2ϩ -ATPase activity in oxidative muscles (22) . These changes are consistent with the typical slow-to-fast-fiber phenoconversion and suggest that disuse per se cannot account for the abnormally low SR function in LTx. Furthermore, training does not increase SR Ca 2ϩ -ATPase content in human muscle (29) . In contrast, there is also some evidence of downregulated SR function with inactivity (22, 46) . Thus the effects of chronic disuse on SR function remain unresolved.
The effects of the immunosuppressant CsA on SR function are unclear. Chronic CsA increased myosin heavy chain type IIa and SERCA1 protein expression in rat soleus muscle, proportional to blood [CsA] (5). Others found that CsA reduced SR Ca 2ϩ -ATPase activity in rabbit fast-twitch muscle (6) , whereas SR Ca 2ϩ uptake in rat white muscle was unchanged (36) . The RyR density in rat white muscle was not affected by CsA (36) , suggesting that depressed Ca 2ϩ release in LTx likely results from RyR inhibition, as found in rat myocardium (4) . We have found that acute CsA addition to rat muscle homogenates depressed SR Ca The gross depression in SR function in LTx must reflect underlying differences in protein content, structural alterations, and/or changes in SR membrane properties that exert regulatory effects, but our results do not distinguish between these possibilities. Depressed SR function does not necessarily imply downregulation of SR protein contents in LTx, as seen with altered muscle activity patterns (25, 34) . Measurement of muscle SR protein contents and isoform expression in LTx is clearly indicated.
Increased Muscle Na
An important finding was that skeletal muscle maximal in vitro Na ϩ -K ϩ -ATPase activity was elevated in LTx, yet, paradoxically, an abnormal plasma K ϩ response to exercise was also evident. Thus LTx exhibited a dissociation between muscle Na ϩ -K ϩ -ATPase and plasma K ϩ regulation during exercise. The nonsignificant difference in Na ϩ -K ϩ -ATPase content (12% higher in LTx) suggests a possible type II error. However, the significant correlation between Na ϩ -K ϩ -ATPase content and activity in controls, but not in LTx, suggests that additional factors affected activity. Na ϩ -K ϩ -ATPase upregulation in LTx is interesting, because reduced Na ϩ -K ϩ -ATPase content in skeletal muscle could be expected as a consequence of chronic muscular disuse and as also seen in heart failure (for references, see Ref. 8) . Upregulated Na ϩ -K ϩ -ATPase in LTx can, in part, be explained by glucocorticoid treatment, which increased muscle Na ϩ -K ϩ -ATPase content in patients with chronic obstructive lung disease (38) and in rats (9) . CsA might also be influential, as CsA inhibited Na ϩ -K ϩ -ATPase activity in rabbit cardiac myocytes (30) . It is unlikely that the increased Na ϩ -K ϩ -ATPase activity in LTx muscle is due to their higher type II muscle fiber proportions, because fibertype dependence for Na ϩ -K ϩ -ATPase content and/or activity has not been detected in human skeletal muscle (14 (33) . The abnormal plasma K ϩ regulation during exercise was independent of both Na ϩ -K ϩ -ATPase content and maximal activity in skeletal muscle. Indeed, the relationship between Na ϩ -K ϩ -ATPase activity and plasma K ϩ variables in LTx was opposite to that seen in controls (14) . The high proportion of type II fibers might contribute to abnormal plasma K ϩ regulation in LTx. In healthy humans, we found no significant relationships between type II fiber proportion and markers of K ϩ regulation. However, with inclusion of LTx, extending the type II fiber maximum to 97%, a significant inverse relationship was found between the type II fiber proportion and the ⌬[K ϩ ]/work. Hence, the type II fiber dominance in these patients might be linked with their poor K ϩ regulation during exercise. This could occur via enhanced K ϩ release from contracting muscles, because K ϩ efflux is greater in glycolytic than in oxidative muscles (8, 27) . Whereas the muscle maximal in vitro Na ϩ -K ϩ -ATPase activity is upregulated in LTx, it is possible that the normal exercise-induced in vivo increase in Na ϩ -K (11) was not due to reduced muscle buffer capacity but is compatible with elevated lactate, impaired mitochondrial ATP production in resting muscle, and early plasma lactate threshold during exercise in LTx (48) .
Functional Consequences of Impaired Muscle Cation Regulation in LTx
Muscle Na ϩ -K ϩ -ATPase plays a crucial role in maintaining membrane excitability and force (8) ATPase activity, and Ca 2ϩ uptake rates in healthy human muscle were depressed with fatigue (26) , which probably also occurs in LTx. Furthermore, impaired mitochondrial function and reduced ATP (11, 48) suggest further inhibition of SR RyR opening and Ca 2ϩ release, leading to muscle fatigue during exercise. The reduced SR Ca 2ϩ uptake in LTx, together with phosphate accumulation, could also limit the Ca 2ϩ available for release (16) . Thus the lower skeletal muscle SR Ca 2ϩ release and Ca 2ϩ -ATPase activity could conceivably make a major contribution to the marked exercise limitation in these patients. Consistent with this, correlations were found between each of the SR function variables and V O 2 peak . These impairments in SR function are thus consistent with, and may even be primarily responsible for, the muscle weakness that persists after lung transplantation (1, 24, 35) .
In conclusion, we demonstrate here a range of abnormalities in Ca 2ϩ , Na ϩ /K ϩ , and H ϩ regulation in peripheral skeletal muscle in LTx. Muscle SR Ca 2ϩ release, Ca 2ϩ uptake, and Ca 2ϩ -ATPase activity were reduced in LTx compared with controls and were considerably subnormal compared with muscle SR function-fiber-type relationships found in healthy controls. The underlying mechanisms are not known, but they may result from chronic disuse, CsA, and disease effects. A paradox was evident between muscle in vitro Na ϩ -K ϩ -ATPase measures, content and activity, which were respectively maintained or increased, and the in vivo measure, plasma [K ϩ ] regulation with exercise, which was impaired. The maintenance of Na ϩ -K ϩ -ATPase activity and content occurred, despite chronic inactivity, possibly due to medication and disease effects. We speculate that impaired muscle Ca 2ϩ and Na ϩ /K ϩ regulation may be important contributory factors in the early muscle fatigue and grossly restricted exercise capacity evident in LTx.
